登录
免费注册
首页
论文
论文详情
赞
收藏
引用
分享
科研之友
微信
新浪微博
Facebook
分享链接
Alemtuzumab-treated patients with active relapsing-remitting multiple sclerosis demonstrate durable slowing of brain volume loss over 5 years with most not receiving treatment for 4 years-CARE-MS I and II extension study
作者:Inshasi Jihad Said; Al Jumah Mohammed; Alroughani Raed; Compston D Alasdair S; Filippi Massimo; Giovannoni Gavin; Havrdova Eva; Yamout Bassem; Margolin David H; Thangavelu Karthinathan
来源:
MENACTRIMS Congress
, 2016-03-17 to 2016-03-19.
出版日期
2016-5
相似论文
引用论文
参考文献